U.S. biopharma is now a Ford Mustang racing against the Chinese-built BYD Yangwang U9 supercarThis essay is part of a First Opinion series on the future of the National Institutes of Health and American science.Around the world, nations with robust research and development infrastructure race to create therapeutics that meet the needs of their residents. […]
